It’s never too early to start thinking about your exit strategy. Knowing where you’re going will help you take the necessary steps to achieve the highest valuation posible. You’ve got options! During this panel discussion we’ll discuss the classic IPO path as well as direct offerings, reverse mergers and Special Purpose Acquisition Companies (SPACs) which have become increasingly popular. Join us to learn how to identify and mitigate potential risks that could diminish the value of your company or IP.
Mike Hostetler, Partner, Patents and Innovations at Wilson Sonsini (Moderator)
Megan Baier, Partner, Corporate at Wilson Sonsini
Andrew McDonald, Founding Partner at LifeSci Venture Partners
Winston Kung, COO & CFO, PMVPharma